2008
DOI: 10.1111/j.1464-5491.2007.02316.x
|View full text |Cite
|
Sign up to set email alerts
|

The islet autoantibody titres: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus

Abstract: Latent autoimmune diabetes in the adult (LADA) is a slowly progressive form of autoimmune diabetes, characterized by diabetes-associated autoantibody positivity. A recent hypothesis proposes that LADA consists of a heterogeneous population, wherein several subgroups can be identified based on their autoimmune status. A systematic review of the literature was carried out to appraise whether the clinical characteristics of LADA patients correlate with the titre and numbers of diabetes-associated autoantibodies. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
58
0
3

Year Published

2009
2009
2017
2017

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 77 publications
(63 citation statements)
references
References 93 publications
(142 reference statements)
2
58
0
3
Order By: Relevance
“…These observations are concordant with other studies regarding LADA [16][17][18]. Patients with newly diagnosed LADA presented with similar fasting glucose and HbA 1c compared to patients with type 2 diabetes, suggesting rather slow progression and relatively asymptomatic clinical onset [17].…”
Section: Discussionsupporting
confidence: 82%
“…These observations are concordant with other studies regarding LADA [16][17][18]. Patients with newly diagnosed LADA presented with similar fasting glucose and HbA 1c compared to patients with type 2 diabetes, suggesting rather slow progression and relatively asymptomatic clinical onset [17].…”
Section: Discussionsupporting
confidence: 82%
“…The level of autoantibodies, particularly GADA, has a clear influence on the phenotype of LADA. A high GADA level is associated with a phenotype more like type 1 diabetes, including reduced beta cell function, increased need for insulin treatment, lower BMI and lower prevalence of dyslipidaemia (reviewed by [5,6]). …”
Section: Introductionmentioning
confidence: 99%
“…However, most of the literature supports the anti-inflammatory and anti-allergic findings done with the AbM-based Andosan ingredient. In line with this and the autoimmune aspect of diabetes [75] is also the observations that AbM ameliorates diabetic disorders in murine models [76,77], as well as in a clinical study on insulin resistance type 2 diabetes [21].…”
Section: Discussionmentioning
confidence: 65%